Harnessing PD-1 Agonists for Novel Therapeutic Approaches in Autoimmune Diseases
Time: 11:00 am
day: Day Two
Details:
- Exploring the novel mechanism of PD-1 agonists in T-cell modulation to treat autoimmune diseases
- Leveraging biomarker data to refine patient selection and optimize therapeutic outcomes
- Integrating translational research insights into clinical strategy for ulcerative colitis and other inflammatory conditions (RA)
